Safety and Clinical Experience of XPO1 Inhibitors in R/R MM Patients : vimarsana.com

Dr. Usmani, MD, MBA, FACP provides insights into Selinexor's safety profile in Relapsed/Refractory Multiple Myeloma (R/R MM), comparing it with other treatments and delve into the ongoing challenges and unmet needs in R/R MM patient care.

Related Keywords

, Clinical Experience , Refractory Multiple Myeloma , Myeloma , Multiple Myeloma , Xpo1 Inhibitors , Rapid Readouts , Evolving Role Of Xpo1 Inhibitors In Multiple Myeloma , Xp01 , Xpo1 ,